Navigation Links
Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
Date:4/25/2008

. Therefore, in order to prevent rabies, preventive vaccination must be applied to dogs, cats and similar animals. However, the homemade attenuated rabies living animal vaccines that are in current, widespread use were long ago phased out in Europe and America. The World Health Organisation has also clearly expressed that they do not support its use because of its safety and questionable immunisation effects (especially as the source of the toxin used for manufacturing the attenuated living vaccine is showing signs of Atavism. The immunisation effect is also poor.) Therefore, there are serious hidden safety problems in the use of this vaccine.

Inactivated rabies vaccines represent the development trend of rabies preventative measures for animals, which has been widely applied in advanced countries. However due to its strict development conditions, there are no homemade supplies available in the domestic market. The imported inactivated vaccine is expensive, so it is difficult to be promoted extensively in China. Facing such a large dog-breeding market and the severe need for rabies prevention, it is imperative to produce homemade inactivated rabies. Therefore, the inactivated rabies vaccine produced by Changzhou Tongtai Bio- pharmaceutical Co., Ltd. will provide a safe, highly effective and low-cost option.

Professor Fu Zhenfang contributed his technology to the project and holds 65% of the shares. He is currently a professor working in the graduate school's pathology and epidemiology departments in the veterinary institute of Georgia University, US. As a famous virus specialist, he is an authoritative figure in the field of bio-products for animal use, especially in the research of rabies. His laboratory has mastered several manufacturing technologies, including inactivated rabies vaccine, parvovirus, hepatitis, canine distemper, and parainfluenza. They have independent intellectual property rights for core technologies of inactivated rabies vaccines
'/>"/>

SOURCE National High-Tech District, Changzhou
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
2. United BioSource Acquires Leading Publication Planning Software and Services Company
3. Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University
4. CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal
5. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
6. Dragon retains leading investor relations firm
7. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
8. Halogen Customers Shape Industry-Leading Employee Performance and Talent Management Solution
9. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
10. ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board
11. Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greeces Leading Biotech Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... Global Resorcinol Market 2015-2019 is ... on the global resorcinol industry. The report highlights the various growth prospects and ... and analysis of primary and secondary inputs from the existing players of the ...
(Date:7/30/2015)... -- AACC welcomed thousands of medical professionals and ... & Clinical Lab Expo in Atlanta ... revolutionary advancements in clinical testing technology and research ... diagnose patients quickly and accurately and make sure ... As of Wednesday, July 29, more than 17,500 ...
(Date:7/30/2015)... 30, 2015 According to a ... Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, ... Clinical Trial), by End Users - Global Forecast to ... to reach USD 2,107.99 million by 2020 from USD ... Browse more than 75 ...
(Date:7/30/2015)... ISN improves the efficiency and effectiveness of contractor management systems. ISN,s online contractor management platform, ... 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Dallas, TX , ISN has additional offices in Calgary , ...
Breaking Biology Technology:Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3
... Jan. 12 The Risk Management and Patient,Safety ... 2009 audio,program calendar. The RM&PSI ( http://www.rmpsi.com ... ), is a national leader in,clinical risk management ... health care institutions. , ...
... The French agency Agence de Medecine,Preventive (AMP) announced ... Director for the SIVAC (Supporting Independent Immunization and,Vaccine ... to,the development of national immunization technical advisory groups ... in Asia. These committees will help,national health authorities ...
... PARK, Ill., Jan. 12 Abbott today is,announcing ... previously issued 2008 earnings-per-share guidance of $3.31 to ... expects earnings per share,of $3.65 to $3.70 under ... basis. The midpoint of this 2009 guidance ...
Cached Biology Technology:The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates 2The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates 3French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees) 2French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees) 3Abbott Announces Earnings Guidance for 2009 2
(Date:7/21/2015)... July 21, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that it has filed provisional patent 62/192218 ... This invention highlights next generation ... an account, but also the user using unique ...
(Date:7/13/2015)... OXFORD, Conn. , Jul. 13, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/188684 for ... NXT-ID achieves another new convenient and secure method ... expands new, innovative payment methods, introduced with its ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced a new Match-in-Sensor™ ... hardware encapsulated fingerprint sensor and matching solution. ... literally off the grid, isolating fingerprint image ... the fingerprint sensor to provide ultimate protection ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... pregnant women have twice the risk of preterm delivery ... to a new study by the Kaiser Permanente Division ... Oxford University Press,s journal Human Reproduction on ... Embryology. The study found that pregnant women with ...
... RIVERSIDE, Calif. The leading cause of death in all ... to chemotherapy, a form of treatment in which chemicals are ... UC Riverside biochemists that focuses on cancer cells reports that ... vegetables and fruit improves cancer cells, response to chemotherapy. ...
... The Marine Mammal Center is seeing a large number of ... a study to determine when and why the sea lions contract ... a surge in the number of sea lions admitted as a ... be lethal for patients. The current research will focus on ...
Cached Biology News:Depression during pregnancy can double risk of preterm delivery 2How eating fruit and vegetables can improve cancer patients' response to chemotherapy 2The Marine Mammal Center begins new leptospirosis study in California 2
... designed for DNA aptamer screening and binding ... powerful Paraflo microfluidic on-chip synthesis platform. Thousands ... on-chip and LC Sciences can provide assistance ... available as part of our comprehensive DNA/RNA ...
... (GST) is commonly used as a fusion ... (1). The GSTTag sequence has been reported ... cases the solubility of its fusion partners. ... form, GSTTag fusion proteins can be purified ...
... a synthetic peptide whose sequence is from the C-terminal end of the ... extends from amino acids 429 to 448 of RAR*. The sequence ... - V - S - P - S - S - V ... - Q - S - P - L - L - Q ...
... is the next step in the evolution ... track system that delivers labware to multiple ... 10 times the throughput of ordinary microplate ... a variety of configurations to meet any ...
Biology Products: